Your browser doesn't support javascript.
loading
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial.
Shah, Sanket; Nandy, Ranjan Kumar; Sethi, Shaily S; Chavan, Bhakti; Pathak, Sarang; Dutta, Shanta; Rai, Sanjay; Singh, Chandramani; Chayal, Vinod; Patel, Chintan; Kumar, N Ravi; Chavan, Abhishek T; Chawla, Amit; Singh, Anit; Roy, Anupriya Khare; Singh, Nidhi; Baik, Yeong Ok; Lee, Youngjin; Park, Youngran; Jeong, Kyung Ho; Ahmed, Syed.
Afiliación
  • Shah S; Techinvention Lifecare Private Limited, Mumbai, India.
  • Nandy RK; Indian Council of Medical Research - National Institute of Cholera and Enteric Diseases, Kolkata, India.
  • Sethi SS; Techinvention Lifecare Private Limited, Mumbai, India.
  • Chavan B; Techinvention Lifecare Private Limited, Mumbai, India.
  • Pathak S; Techinvention Lifecare Private Limited, Mumbai, India.
  • Dutta S; Indian Council of Medical Research - National Institute of Cholera and Enteric Diseases, Kolkata, India.
  • Rai S; All India Institute of Medical Sciences, New Delhi, India.
  • Singh C; All India Institute of Medical Sciences, Patna, India.
  • Chayal V; Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, India.
  • Patel C; Aatman Hospital, Ahmedabad, India.
  • Kumar NR; Niloufer Hospital, Hyderabad, India.
  • Chavan AT; Jeevan Rekha Hospital, Belagavi, India.
  • Chawla A; Prakhar Hospital, Kanpur, India.
  • Singh A; Clinical Research Network India, Noida, India.
  • Roy AK; Clinical Research Network India, Noida, India.
  • Singh N; Clinical Research Network India, Noida, India.
  • Baik YO; EuBiologics Co., Ltd., Seoul, South Korea.
  • Lee Y; EuBiologics Co., Ltd., Seoul, South Korea.
  • Park Y; EuBiologics Co., Ltd., Seoul, South Korea.
  • Jeong KH; EuBiologics Co., Ltd., Seoul, South Korea.
  • Ahmed S; Techinvention Lifecare Private Limited, Mumbai, India.
Lancet Reg Health Southeast Asia ; 19: 100256, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38076719
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Lancet Reg Health Southeast Asia Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Lancet Reg Health Southeast Asia Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido